Characterization and Proteomic Analysis of Decellularized Adipose Tissue Hydrogels Derived from Lean and Overweight/Obese Human Donors.
Omair A MohiuddinJessica M MotherwellEmma RogersMelyssa R BrattonQiang ZhangGuangdi WangBruce A BunnellDaniel J HayesJeffrey M GimblePublished in: Advanced biosystems (2020)
While decellularized adipose tissue (DAT) has potential as an "off-the-shelf" biomaterial product for regenerative medicine, it remains to be determined if donor-source body mass index (BMI) impacts the functionality of DAT. This study set out to comparatively characterize lean versus overweight/obese-donor derived DAT hydrogel based on proteome and to analyze their respective effects on adipose stromal/stem cell (ASC) viability, and differentiation in vitro. Decellularized adipose tissue from lean (lDAT) and overweight/obese (oDAT) donors is produced and characterized. Variability in the fibril microstructures is found, with dense fibrotic fiber clusters and large pore area uniquely present in the oDAT samples. Proteomic analysis reveals that lDAT contains a greater proportion of enriched extracellular proteins and a smaller proportion of enriched intracellular proteins relative to oDAT. Biocompatibility studies show that ASCs cultured in lDAT and oDAT hydrogels remain viable. The adipogenic and osteogenic differentiation capability of ASCs seeded in lDAT and oDAT hydrogels is confirmed by an upregulation in marker gene expression and phenotypic analysis. In conclusion, this study establishes that DAT hydrogels derived from lean and overweight/obese adipose donors present similar physicochemical profiles with some distinctive features while comparably supporting the viability and adipogenic differentiation of ASCs in vitro.
Keyphrases
- adipose tissue
- tissue engineering
- weight loss
- extracellular matrix
- weight gain
- insulin resistance
- body mass index
- drug delivery
- high fat diet
- hyaluronic acid
- gene expression
- physical activity
- stem cells
- endothelial cells
- bariatric surgery
- bone marrow
- drug release
- wound healing
- type diabetes
- cell proliferation
- metabolic syndrome
- obese patients
- mesenchymal stem cells
- dna methylation
- kidney transplantation
- systemic sclerosis
- reactive oxygen species
- nlrp inflammasome